Among the medicines to be produced at the site will be orforglipron, the company’s oral small-molecule GLP-1 receptor agonist ...
There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback